It seems to me we have been anticipating the FDA's assessment of CSL112 for the best part of 2 decades...I'd like to think CSL would have pulled the plug on this potential blockbuster long before now if they were not pretty convinced that CSL112 will quickly become the standard-of-care therapy for the misfortunate folks who suffer a heart attack.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$272.11 |
Change
1.520(0.56%) |
Mkt cap ! $131.7B | |||
| Open | High | Low | Value | Volume |
| $269.50 | $272.50 | $268.56 | $93.74M | 346.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 22451 | $299.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $244.90 | 7974 | 2 |
View Market Depth
| Last trade - 15.59pm 29/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |